Assessment of the Negative Factors for the Clinical Outcome in Patients with SARS-CoV-2 Infection and Type 2 Diabetes Mellitus
Oana Albai,Adina Braha,Bogdan Timar,Alexandra Sima,Loredana Deaconu,Romulus Timar
DOI: https://doi.org/10.2147/dmso.s447835
2024-01-23
Diabetes Metabolic Syndrome and Obesity Targets and Therapy
Abstract:Oana Albai, 1– 3 Adina Braha, 1, 2 Bogdan Timar, 1– 3 Alexandra Sima, 1– 3 Loredana Deaconu, 1 Romulus Timar 1– 3 1 Department of Second Internal Medicine- Diabetes, Nutrition, Metabolic Diseases, and Systemic Rheumatology, "victor Babes" University of Medicine and Pharmacy, Timisoara, 300041, Romania; 2 Department of Diabetes, Nutrition and Metabolic Diseases Clinic, "Pius Brînzeu" Emergency Clinical County University Hospital, Timisoara, 300723, Romania; 3 Centre for Molecular Research in Nephrology and Vascular Disease/MOL-NEPHRO-VASC, "Victor Babes" University of Medicine and Pharmacy, Timisoara, 300041, Romania Correspondence: Adina Braha, Department of Second Internal Medicine- Diabetes, Nutrition, Metabolic Diseases, and Systemic Rheumatology, Victor Babes" University of Medicine and Pharmacy, 2 Eftimie Murgu Square, Timisoara, 300041, Romania, Email Purpose: Patients with diabetes mellitus (DM) are more susceptible to viral and bacterial infections, facing a more severe prognosis and higher mortality rates. The study's main aim was to evaluate the survival and mortality rates of patients with type 2 diabetes (T2DM) and SARS-CoV-2 virus infection alongside the main factors influencing the prognosis. Patients and Methods: The present study included 186 patients with T2DM and SARS-CoV-2 virus infection admitted to the COVID-19 Department of the "Pius Brînzeu" Emergency Clinical County University Hospital between November 2020 and March 2021. Patients had investigations performed upon arrival in the emergency room and during hospitalization. We analyzed the risk of negative prognosis based on clinical data (oxygen saturation (SatO2), respiratory rate (RR), lung damage), glycemic control (HbA1c, glycemia at hospital admission), and the duration of T2DM. Results: The mortality rate in the studied group was 36.6%. All deceased patients had previously been diagnosed with hypertension; 95.58% had a body mass index (BMI) greater than 25 kg/m 2 , and 79.41% presented with cardiovascular disease (CVD). Compared to those who recovered, statistically significant differences were observed in BMI, glycemic levels at admission, glycosylated hemoglobin levels (HbA1c), SatO2, RR, and lung damage. Valid statistically significant predictors for death in T2DM patients with COVID-19 were hyperglycemia at admission > 198mg/dl, HbA1c> 8.6%, and SatO2≤ 87%. Conclusion: SatO2, glycemia at hospital admission, and HbA1c had the highest sensitivity and specificity to predict the prognosis of T2DM patients with SARS-CoV-2 infection. Glycemic control is essential in the prognosis of patients with DM and COVID-19 infection. The prognosis was worse if other comorbidities were associated, especially hypertension and CVD. Keywords: SARS-CoV-2 infection, type 2 diabetes mellitus, negative prognostic factors, mortality rate On March 11, 2020, the World Health Organization (WHO) declared the Coronavirus Infectious Disease 2019 (COVID-19) a global pandemic due to the rapid spread of this virus. Three years after the first case of COVID-19 was identified in the city of Wuhan in China, several questions related to the SARS-CoV-2 virus need to be answered. 1,2 Worldwide, nearly 700 million people have been affected, and approximately 7 million have died, causing a severe crisis in many areas. 3 Some individuals have been more severely affected by the new SARS-CoV-2 coronavirus, namely the elderly, those with chronic diseases, respiratory diseases, cardiovascular diseases (CVD), DM, and even those with obesity presenting a higher risk of developing severe forms, even death. 4–6 T2DM represent an independent predictor for morbidity and mortality in patients with SARS-CoV-2 infection. Patients with obesity frequently present respiratory dysfunction, with changes in respiratory mechanisms, altered gas exchange, and decreased muscle strength. They risk developing more frequent severe pneumonia associated with hypoventilation and pulmonary hypertension than those without obesity. Obesity is also associated with DM, CVD, renal impairment, comorbidities that increase susceptibility to cardiovascular events, infection, and an altered immune response. 7–10 Like all other coronaviruses, SARS-CoV-2 has four structural proteins: E (coat protein), M (membrane protein), N (nucleocapsid protein), S (spike protein), and eight accessory proteins. The spike surface glycoprotein plays an essential role by promoting the attachment of the virus to its receptor on host cells. Thus, it can determine host tropism and transmissibility. 11 SARS-CoV-2 uses ACE-2 as a cellular entry receptor. The ACE-2 receptor is a type -Abstract Truncated-
endocrinology & metabolism